Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines.

@article{Laine2009PrescriptionRO,
  title={Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines.},
  author={L Laine and Laurine G Connors and Marie R. Griffin and Sean P. Curtis and Amarjot Kaur and Christopher P. Cannon},
  journal={Alimentary pharmacology & therapeutics},
  year={2009},
  volume={30 7},
  pages={767-74}
}
BACKGROUND Protective co-therapy is recommended in NSAID users with GI risk factors, but adherence is poor. AIM To assess the proportion of NSAID users receiving co-therapy and strategies to improve adherence. METHODS Arthritis patients > or =50 years of age received etoricoxib or diclofenac in a double-blind randomized trial. Reminders that high-risk patients (age > or = 65; previous ulcer/haemorrhage; corticosteroid, anticoagulant, aspirin use) should receive co-therapy were given at… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…